Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Action Observation and Motor Imagery Induced Hypoalgesia in Asymptomatic Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03959449
Recruitment Status : Not yet recruiting
First Posted : May 22, 2019
Last Update Posted : May 24, 2019
Sponsor:
Information provided by (Responsible Party):
Roy La Touche Arbizu, Universidad Autonoma de Madrid

Brief Summary:
This study evaluates the influence of motor imagery and the observation of actions on pain perception. Participants in this study are asymptomatic subjects who will perform an IM and AO protocol of an aerobic exercise.

Condition or disease Intervention/treatment Phase
Analgesia Exercise Behavioral: Action Observation plus motor imagery Behavioral: Motor imagery Behavioral: Exercise plus action Observation and motor imagery Not Applicable

Detailed Description:
Motor Imagery (MI) is defined as a dynamic mental process that involves the representation of an action, in an internal way, without its actual motor execution. The Action Observation (AO) evokes an internal, real-time motor simulation of the movements that the observer is perceiving visually. Both mental processes trigger the activation of the neurocognitive mechanisms that underlie the planning and execution of voluntary movements in a manner that resembles how the action is performed in a real manner. The phenomenon of exercise-induced hypoalgesia is well known. This is why it has been suggested that these techniques could produce pain modulation similar to that produced by real exercise.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Action Observation and Motor Imagery Induced Hypoalgesia in Asymptomatic Subjects
Estimated Study Start Date : June 5, 2019
Estimated Primary Completion Date : June 30, 2019
Estimated Study Completion Date : July 15, 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Action Observation and Motor imagery Behavioral: Action Observation plus motor imagery
Action observation (video) and motor imagery of running.

Active Comparator: Motor Imagery Behavioral: Motor imagery
Motor imagery of running

Experimental: Exercise plus motor imagery and action observation Behavioral: Exercise plus action Observation and motor imagery
Real exercise of running during 6 min plus action observation (video) and motor imagery of running.




Primary Outcome Measures :
  1. Pain pressure threshold [ Time Frame: Change from baseline and immediately post-intervention ]
    Pressure Pain Threshold (PPT) is one of these tests and it is defined as the minimum force applied which induces pain. The measurement shall be carried out by using an algometer (pressure device that induces mechanical stimuli) is to standardize the amount of pressure applied in the neck region. The reliability of pressure pain thresholds according to raters or measurement frequencies is relatively high


Secondary Outcome Measures :
  1. Visual and Kinesthetic Motor Imagery Ability [ Time Frame: Immediately before the intervention ]
    Visual and Kinesthetic Motor Imagery Ability will be measured with Movement Imagery Questionnaire-Revised (MIQ-R). MIQ-R has four movements repeated in two subscales, a visual and a kinesthetic one. Additionally, a score between 1 and 7 is assigned, with 1 representing difficulty in picturing the motor image or difficulty in feeling the movement previously made, and 7 representing the maximum ease. The internal consistencies of the MIQ-R have been consistently adequate with Cronbach's α coefficients ranging above 0.84 for the total scale, 0.80 for de visual subscale and 0.84 for the kinesthetic subscale (Campos & González, 2010).

  2. The degree of physical activity [ Time Frame: Immediately before the intervention ]
    The degree of physical activity was objectified through the The International Physical Activity Questionnaire (IPAQ) questionnaire, which allows the subjects to be divided into three groups according to their level of activity, which can be high, moderate, and low or inactive. The IPAQ consists of 7 questions about the frequency, duration and intensity of activity (moderate and intense) performed in the last seven days, as well as walking and sitting time on a workday. The IPAQ scoring protocol assigns the following MET values to walking, moderate, and vigorous intensity activity: 3.3 METs, 4.0 METs, and 8.0 METs, respectively.

  3. Kinesiophobia [ Time Frame: Immediately before the intervention ]
    Fear of movement or kinesiophobia will be quantified with the Spanish version of the Kinesiophobia Tampa Scale (TSK-11). This instrument demonstrates reliability and validity in patients with chronic pain, being shorter than the original scale. The total score ranges from 11 to 44 points, with the highest scores indicating greater fear of a new injury due to movement

  4. Electrodermal Activity [ Time Frame: Change in electrodermal activity after 5 minutes post-intervention ]
    Electrodermal Activity will be measured through the use of two electrodes that recorded changes in conductance through the skin located at the back of the dominant hand

  5. Respiration Rate [ Time Frame: Change in electrodermal activity after 5 minutes post-intervention ]
    Respiration Rate will be measured through a pressure transducer located in the centre of the chest, where it was fixed by a strap

  6. Respiration Rate [ Time Frame: Change in electrodermal activity after 5 minutes post-intervention ]
    Heart Rate will be measured by three electrodes located in the left area of the chest. One of the electrodes was placed in the middle zone while a second electrode was positioned on the lateral side, and a third one on the lower left side, below the first electrode.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Age between 18 and 60
  • Healthy and with no pain subjects

Exclusion Criteria:

  • Any cognitive impairment that hindered viewing of audiovisual material.
  • Difficulty understanding or communicating.
  • Presence of systemic pathology, Central Nervous System or rheumatic disease.
  • Inadequate understanding of the Spanish language to follow instructions for measuring and treatment.
  • Collaboration of pregnant women.
  • Underage subjects
  • Subjects with pain at the time of the study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03959449


Contacts
Layout table for location contacts
Contact: Roy La Touche +349174019803 roylatouche@yahoo.es
Contact: Luis Suso Marti +349174019803 luis.suso@gmail.com

Locations
Layout table for location information
Spain
CSEU La Salle Not yet recruiting
Madrid, Spain, 28023
Contact: Roy La Touche    917401980    roylatouche@yahoo.es   
Sponsors and Collaborators
Universidad Autonoma de Madrid

Layout table for additonal information
Responsible Party: Roy La Touche Arbizu, Principal Investigator, Universidad Autonoma de Madrid
ClinicalTrials.gov Identifier: NCT03959449     History of Changes
Other Study ID Numbers: uammadrid8
First Posted: May 22, 2019    Key Record Dates
Last Update Posted: May 24, 2019
Last Verified: May 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Roy La Touche Arbizu, Universidad Autonoma de Madrid:
Motor imagery
Action observation
Hypoalgesia